Table 1.
AKI in COVID
All (n=111) | Discharged (n=53) | In-hospital mortality (n=58) | P | |
---|---|---|---|---|
AKI | ||||
Stage 1 | 20 (18%) | 13 (25%) | 7 (12%) | 0.139 |
Stage 2 | 16 (14%) | 9 (17%) | 7 (12%) | |
Stage 3 | 75 (68%) | 31 (58%) | 44 (76%) | |
Need for RRT | 45 (40.5%) | 15 (28.3%) | 30 (50%) | 0.022 |
AKI on CKD | 23 (20.7%) | 13 (24.5%) | 10 (17%) | 0.360 |
Duration of RRT (days) | ||||
<4 | 22 (49%) | 1 (7%) | 21 (70%) | <0.001 |
5-9 | 16 (35.5%) | 9 (60%) | 7 (23%) | |
>10 | 7 (15.5%) | 5 (34%) | 2 (7%) | |
Renal recovery at discharge | ||||
Complete | 31 (28%) | 31 (58%) | 0 | <0.001 |
Partial | 20 (18%) | 20 (38%) | 0 | |
No recovery | 2 (2%) | 2 (4%) | 0 | |
Expired | 58 (52%) | 0 | 58 (100%) | |
Renal Recovery at 3 months | ||||
Recovered | 23 (20.7%) | 23 (43%) | 0 | |
CKD Progression | 26 (23.4%) | 26 (49%) | 0 | |
Expired | 62 (55.85%) | 4 (8%) | 58 (100%) |
AKI=acute kidney injury; RRT=renal replacement therapy; CKD=chronic kidney disease. P value less than 0.5 is considered significant and has been highlighted in bold